Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials

Alex Z. Wang, Amir H. Lebastchi, Luke P. O’Connor, Michael Ahdoot, Sherif Mehralivand, Nitin Yerram, Samir S. Taneja, Arvin K. George, Rafael Sanchez-Salas, John F. Ward, Pilar Laguna, Jean de la Rosette, Peter A. Pinto

    Research output: Contribution to journalArticlepeer-review

    Fingerprint Dive into the research topics of 'Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials'. Together they form a unique fingerprint.

    Medicine & Life Sciences